PAN-31415-07512
3 vaccinations
1 coded response
28 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 371 / TN
- Registered
- 2021-04-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-16
Registered in v-safe
-
2021-04-16
Dose 1 — Pfizer-BioNTech
- 2021-04-16
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-30
-
2021-05-07
Dose 2 — Pfizer-BioNTech
-
2021-05-07
Health check-in — day 0, dose 2Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-05-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-16
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-06-20
- 2021-08-06
- 2021-11-05
-
2021-12-01
Dose 3 — Pfizer-BioNTech
- 2021-12-29
- 2022-01-05
- 2022-01-14
- 2022-03-02
-
2022-06-01
Survey response — 6 months, dose 3MedDRA: Appendicitis, Endometriosis, Ovarian cyst — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Appendicitis, ovarian cyst and endometriosisMedDRA releases: 2024-11 · check-in free text available
-
2022-06-01
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2022-06-02
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-12-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-16 | Pfizer-BioNTech | |
| 2 | 2021-05-07 | Pfizer-BioNTech | |
| 3 | 2021-12-01 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 6 months, dose 3
Symptoms: Appendicitis, ovarian cyst and endometriosis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Appendicitis | · | · | ✓ |
| SD | Endometriosis | · | · | ✓ |
| SD | Ovarian cyst | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release